Bicycle Therapeutics Plc financial data

Symbol
BCYC on Nasdaq
Location
Cambridge, United Kingdom
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.23K % -2.25%
Debt-to-equity 21.8 % -30.6%
Return On Equity -35.5 % -29.9%
Return On Assets -29.2 % -40.2%
Operating Margin -1.02K % -92.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30M shares +1.33%
Common Stock, Shares, Outstanding 69.3M shares +0.42%
Entity Public Float 759M USD -1.11%
Common Stock, Value, Issued 894K USD +0.45%
Weighted Average Number of Shares Outstanding, Basic 69.3M shares +0.46%
Weighted Average Number of Shares Outstanding, Diluted 69.3M shares +0.46%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 28.3M USD -23.2%
Research and Development Expense 238M USD +41.9%
General and Administrative Expense 80.1M USD +22.3%
Operating Income (Loss) -290M USD -47.6%
Nonoperating Income (Expense) 37.2M USD +38.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -253M USD -49.1%
Income Tax Expense (Benefit) -2.2M USD +34.7%
Net Income (Loss) Attributable to Parent -251M USD -50.7%
Earnings Per Share, Basic -3 USD/shares -12.3%
Earnings Per Share, Diluted -3 USD/shares -12.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 648M USD -27.2%
Accounts Receivable, after Allowance for Credit Loss, Current 136K USD
Assets, Current 739M USD -23.5%
Property, Plant and Equipment, Net 6.86M USD -40.4%
Operating Lease, Right-of-Use Asset 4.56M USD -49.8%
Other Assets, Noncurrent 13.7M USD +37.9%
Assets 764M USD -23.4%
Accounts Payable, Current 12.7M USD +121%
Employee-related Liabilities, Current 14.9M USD +14.6%
Accrued Liabilities, Current 44.4M USD +12.9%
Liabilities, Current 69.3M USD +22.8%
Operating Lease, Liability, Noncurrent 981K USD -82.3%
Other Liabilities, Noncurrent 1.09M USD -81.7%
Liabilities 145M USD -12.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.47M USD -8.98%
Retained Earnings (Accumulated Deficit) -880M USD -39.9%
Stockholders' Equity Attributable to Parent 618M USD -25.6%
Liabilities and Equity 764M USD -23.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -86.4M USD -21.9%
Net Cash Provided by (Used in) Financing Activities 1.87M USD -31.2%
Net Cash Provided by (Used in) Investing Activities -604K USD -4933%
Common Stock, Shares Authorized 160M shares +2.45%
Common Stock, Shares, Issued 69.3M shares +0.42%
Common Stock, Par or Stated Value Per Share 0.01 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -86.5M USD -24.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 649M USD -27.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 686K USD +1.03%
Deferred Tax Assets, Valuation Allowance 99.7M USD +24.2%
Deferred Tax Assets, Gross 112M USD +26.5%
Operating Lease, Liability 5.54M USD -49.2%
Depreciation 6.6M USD +11.9%
Payments to Acquire Property, Plant, and Equipment 604K USD +4933%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -251M USD -45.6%
Property, Plant and Equipment, Gross 28.2M USD +0.64%
Operating Lease, Liability, Current 4.56M USD -15.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 821K USD -76.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.46M USD -42.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -1.32M USD -71.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 246K USD -71.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 821K USD -75.4%
Deferred Tax Assets, Operating Loss Carryforwards 81.5M USD +22.4%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 821K USD 0%
Operating Lease, Payments 1.45M USD +1.32%
Additional Paid in Capital 1.5B USD +2.63%
Depreciation, Depletion and Amortization 1.63M USD -1.45%
Share-based Payment Arrangement, Expense 38.1M USD +7.27%
Interest Expense 3.28M USD -1.74%